miR-375 maintains normal pancreatic α- and β-cell mass
Open accessThe DOI matches its Crossref record; 37 of the 37 references it cites were found in a registry or an index.
Abstract
Altered growth and development of the endocrine pancreas is a frequent cause of the hyperglycemia associated with diabetes. Here we show that microRNA-375 ( miR-375 ), which is highly expressed in pancreatic islets, is required for normal glucose homeostasis. Mice lacking miR-375 ( 375KO ) are hyperglycemic, exhibit increased total pancreatic α-cell numbers, fasting and fed plasma glucagon levels, and increased gluconeogenesis and hepatic glucose output. Furthermore, pancreatic β-cell mass is decreased in 375KO mice as a result of impaired proliferation. In contrast, pancreatic islets of obese mice ( ob / ob ), a model of increased β-cell mass, exhibit increased expression of miR-375 . Genetic deletion of miR-375 from these animals ( 375 / ob ) profoundly diminished the proliferative capacity of the endocrine pancreas and resulted in a severely diabetic state. Bioinformatic analysis of transcript data from 375KO islets revealed that miR-375 regulates a cluster of genes controlling cellular growth and proliferation. These data provide evidence that miR-375 is essential for normal glucose homeostasis, α- and β-cell turnover, and adaptive β-cell expansion in response to increasing insulin demand in insulin resistance.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source doesn’t support the claim as written.
In the citing paper
“knockout of miR-375 promotes progressive hyperglycemia in mouse models due to decreased insulin content and progressive loss of β-cell mass ( 32 ).”
From β-Cell Failure in Type 2 Diabetes: Postulated Mechanisms and Prospects for Prevention and Treatment (2014) · cites this paper as [32]
Checked by a reasoning model — may be wrong.
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“Mir-375 is also involved in adaptive β-cell expansion in response to insulin resistance (518).”
From Pancreatic β-Cell Electrical Activity and Insulin Secretion: Of Mice and Men (2018) · cites this paper as [518]
In the citing paper
“miR-375 also regulates many genes involved in cellular proliferation, which likely underlies its effect on the maintenance of beta cell mass.”
From The Vasculature in Prediabetes (2018) · cites this paper as [139]
In the citing paper
“miR-375, an islet-specific microRNA that regulates both insulin secretion and beta cell mass.”
From The Vasculature in Prediabetes (2018) · cites this paper as [139]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Bartel (2004) · doi:10.1016/s0092-8674(04)00045-5 · Cited by 34,714
The functions of animal microRNAs
Ambros, V. (2004) · Nature · doi:10.1038/nature02871 · Cited by 10,728
Microarray analysis shows that some microRNAs downregulate large numbers of target mRNAs
Lim, L. P., Lau, N. C., Garrett-Engele, P., Grimson, A., Schelter, J. M., Castle, J., Bartel, D. P., Linsley, P. S., & Johnson, J. M. (2005) · Nature · doi:10.1038/nature03315 · Cited by 4,755 · cited 1×
“Previous studies have established that miRNAs can negatively regulate the mRNA level of their direct targets (15), and that miRNA loss of function can result in the up-regulation of hundreds of genes (16).”
BackgroundSilencing of microRNAs in vivo with ‘antagomirs’
Krützfeldt, J., Rajewsky, N., Braich, R., Rajeev, K. G., Tuschl, T., Manoharan, M., & Stoffel, M. (2005) · Nature · doi:10.1038/nature04303 · Cited by 3,949 · cited 2×
“Previous studies have established that miRNAs can negatively regulate the mRNA level of their direct targets (15), and that miRNA loss of function can result in the up-regulation of hundreds of genes (16).”
BackgroundMethodSelf-citationA pancreatic islet-specific microRNA regulates insulin secretion
Poy, M. N., Eliasson, L., Krutzfeldt, J., Kuwajima, S., Ma, X., MacDonald, P. E., Pfeffer, S., Tuschl, T., Rajewsky, N., Rorsman, P., et al. (2004) · Nature · doi:10.1038/nature03076 · Cited by 2,102 · cited 6×
“Northern blotting, Western blotting, and luciferase assays were performed as previously described (13).”
BackgroundMethodResultInfluentialSelf-citationControl of Stress-Dependent Cardiac Growth and Gene Expression by a MicroRNA
van Rooij, E., Sutherland, L. B., Qi, X., Richardson, J. A., Hill, J., & Olson, E. N. (2007) · Science · doi:10.1126/science.1139089 · Cited by 1,657 · cited 1×
“For instance, tissue-enriched miRNAs in the heart, such as miR-1, miR-208, and miR-133, have been shown to regulate the hypertrophic proliferative activity in response to a variety of stresses, and miR-126 affects survival after induction of a myocardial infarction (7, 12, 33).”
BackgroundThe Endothelial-Specific MicroRNA miR-126 Governs Vascular Integrity and Angiogenesis
Wang, S., Aurora, A. B., Johnson, B. A., Qi, X., McAnally, J., Hill, J. A., Richardson, J. A., Bassel-Duby, R., & Olson, E. N. (2008) · Developmental Cell · doi:10.1016/j.devcel.2008.07.002 · Cited by 1,617 · cited 1×
“For instance, tissue-enriched miRNAs in the heart, such as miR-1, miR-208, and miR-133, have been shown to regulate the hypertrophic proliferative activity in response to a variety of stresses, and miR-126 affects survival after induction of a myocardial infarction (7, 12, 33).”
BackgroundRegulation of the Germinal Center Response by MicroRNA-155
Thai, T.-H., Calado, D. P., Casola, S., Ansel, K. M., Xiao, C., Xue, Y., Murphy, A., Frendewey, D., Valenzuela, D., Kutok, J. L., et al. (2007) · Science · doi:10.1126/science.1141229 · Cited by 1,477
Dysregulation of Cardiogenesis, Cardiac Conduction, and Cell Cycle in Mice Lacking miRNA-1-2
Zhao, Y., Ransom, J. F., Li, A., Vedantham, V., von Drehle, M., Muth, A. N., Tsuchihashi, T., McManus, M. T., Schwartz, R. J., & Srivastava, D. (2007) · Cell · doi:10.1016/j.cell.2007.03.030 · Cited by 1,429
Advances in Male Contraception
Page, S. T., Amory, J. K., & Bremner, W. J. (2008) · Endocrine Reviews · doi:10.1210/er.2007-0041 · Cited by 1,134
Cited by
Items 201–300 of 767
Dysregulation of Dicer1 in Beta Cells Impairs Islet Architecture and Glucose Metabolism
Mandelbaum, A. D., Melkman-Zehavi, T., Oren, R., Kredo‐Russo, S., Nir, T., Dor, Y., & Hornstein, E. (2012) · Experimental Diabetes Research · doi:10.1155/2012/470302 · Cited by 66
Pharmacogenomics of Oral Antidiabetic Medications: Current Data and Pharmacoepigenomic Perspective
Manolopoulos, V. G., Ragia, G., & Tavridou, A. (2011) · Pharmacogenomics · doi:10.2217/pgs.11.65 · Cited by 74
MiR-132 controls pancreatic beta cell proliferation and survival through Pten/Akt/Foxo3 signaling
Mziaut, H., Henniger, G., Ganss, K., Hempel, S., Wolk, S., McChord, J., Chowdhury, K., Ravassard, P., Knoch, K.-P., Krautz, C., et al. (2020) · Molecular Metabolism · doi:10.1016/j.molmet.2019.11.012 · Cited by 65
MicroRNAs in islet hormone secretion
Esguerra, J. L. S., Nagao, M., Ofori, J. K., Wendt, A., & Eliasson, L. (2018) · Diabetes Obesity and Metabolism · doi:10.1111/dom.13382 · Cited by 69
Role of MicroRNAs in Islet Beta-Cell Compensation and Failure during Diabetes
Plaisance, V., Waeber, G., Regazzi, R., & Abderrahmani, A. (2014) · Journal of Diabetes Research · doi:10.1155/2014/618652 · Cited by 71
“The first one for which a major role in pancreatic development has been demonstrated is miR375 (Table 1) [22, 42].”
BackgroundAnti-inflammatory effects of grape seed procyanidin B2 on a diabetic pancreas
Yin, W., Li, B., Li, X., Yu, F., Cai, Q., Zhang, Z., Cheng, M., & Gao, H. (2015) · Food & Function · doi:10.1039/c5fo00496a · Cited by 67
Wang, N., Zhu, Y., Xie, M., Wang, L., Jin, F., Li, Y., Yuan, Q., & De, W. (2018) · Cellular Physiology and Biochemistry · doi:10.1159/000487983 · Cited by 65
MiRNAs in β-Cell Development, Identity, and Disease
Martínez-Sánchez, A., Rutter, G. A., & Latreille, M. (2017) · Frontiers in Genetics · doi:10.3389/fgene.2016.00226 · Cited by 74
“For example, early studies by Poy et al. (2009) demonstrated that miR-375 is required for β-cell compensation in leptin-deficient mice, whereas the study by Jacovetti et al. (2012) did not find differences in the expression of this miRNA during pregnancy.”
BackgroundResultInfluentialBelongie, K., Ferrannini, E., Johnson, K., Andrade‐Gordon, P., Hansen, M. K., & Petrie, J. R. (2017) · PLoS ONE · doi:10.1371/journal.pone.0182932 · Cited by 69
Jafarian, A., Taghikani, M., Abroun, S., Allahverdi, A., Lamei, M., Lakpour, N., & Soleimani, M. (2015) · PLoS ONE · doi:10.1371/journal.pone.0128650 · Cited by 63
“On the other hand, functional knockdown of miR-375 in mice by using 2'-o-methyl antisense oligonucleotides had a converse effect and increased the insulin secretion in response to glucose [45].”
BackgroundChien, H.-Y., Lee, T.-P., Chen, C.-Y., Chiu, Y.-H., Lin, Y.-C., Lee, L.-S., & Li, W. (2014) · Journal of the Chinese Medical Association · doi:10.1016/j.jcma.2014.11.002 · Cited by 68
Yan, M., Wang, Y., Hu, Y., Feng, Y., Dai, C., Wu, J., Wu, D., Zhang, F., & Zhai, Q. (2013) · Analytical Chemistry · doi:10.1021/ac4036026 · Cited by 61
Al‐Kafaji, G., Al-Mahroos, G., Al-Muhtaresh, H. A., Sabry, M. A., Razzak, R. L. A., & Salem, A. H. (2016) · Biomarkers · doi:10.1080/1354750x.2016.1204004 · Cited by 65
“RNU6B was also shown in many studies as one of the control genes with the least variability for miRNAs assays (Wong et al., 2007) and was used widely in different fields including diabetes research (Al-Kafaji et al., 2015; Poy et al., 2009; Roggli et al., 2010).”
BackgroundExtracellular miRNAs as mediators of obesity‐associated disease
Brandão, B. B., Lino, M., & Kahn, C. R. (2021) · The Journal of Physiology · doi:10.1113/jp280910 · Cited by 64
“Numerous miRNAs have also been found to be secreted from pancreatic islets (Baroukh & Van Obberghen, 2009; Poy et al. 2009; Filios & Shalev, 2015; Eliasson, 2017; Iacomino & Siani, 2017; Xu et al. 2020).”
BackgroundKim, J.-W., You, Y.-H., Jung, S., Suh‐Kim, H., Lee, I.-K., Cho, J.-H., & Yoon, K. (2013) · Diabetologia · doi:10.1007/s00125-012-2812-x · Cited by 64
MicroRNAs in common diseases and potential therapeutic applications
Tsai, L. M., & Yu, D. (2009) · Clinical and Experimental Pharmacology and Physiology · doi:10.1111/j.1440-1681.2009.05269.x · Cited by 68
“Mice lacking miR-375 are hyperglycaemic: they exhibit increased total numbers of pancreatic a-cells, fasting and fed plasma glucagon levels and increased gluconeogenesis and hepatic glucose output, whereas pancreatic b-cell mass is decreased as a result of impaired proliferation.(40)”
BackgroundStem cell approaches for diabetes: towards beta cell replacement
Weir, G. C., Cavelti‐Weder, C., & Bonner‐Weir, S. (2011) · Genome Medicine · doi:10.1186/gm277 · Cited by 66
TGF-β upregulates miR-182 expression to promote gallbladder cancer metastasis by targeting CADM1
Qiu, Y., Luo, X., Kan, T., Zhang, Y., Yu, W., Wei, Y., Shen, N., Yi, B., & Jiang, X. (2013) · Molecular BioSystems · doi:10.1039/c3mb70479c · Cited by 61
miR-184 Regulates Pancreatic β-Cell Function According to Glucose Metabolism
Tattikota, S. G., Rathjen, T., Hausser, J., Khedkar, A., Kabra, U. D., Pandey, V., Sury, M. D., Wessels, H., Mollet, I. G., Eliasson, L., et al. (2015) · Journal of Biological Chemistry · doi:10.1074/jbc.m115.658625 · Cited by 63
Self-citationmiR-375 Mediated Acquired Chemo-Resistance in Cervical Cancer by Facilitating EMT
Shen, Y., Zhou, J., Li, Y., Ye, F., Wan, X., Lü, W., Xie, X., & Cheng, X. (2014) · PLoS ONE · doi:10.1371/journal.pone.0109299 · Cited by 64
“miR-375 was initially found to be expressed in pancreatic islet, where it regulates the secretion of insulin and metabolism of glucose [17].”
BackgroundmiR-375 Inhibits Proliferation of Mouse Pancreatic Progenitor Cells by Targeting YAP1
Zhang, Z., Men, T., Feng, R.-C., Li, Y.-C., Zhou, D., & Teng, C. (2013) · Cellular Physiology and Biochemistry · doi:10.1159/000356614 · Cited by 62
Delić, D., Eisele, C., Schmid, R., Luippold, G., Mayoux, E., & Grempler, R. (2016) · International Journal of Molecular Sciences · doi:10.3390/ijms17050665 · Cited by 65
“Alterations of miRNAs within the islets have also been reported in many animal models, such as obese models for T2D using ob/ob mice [16], db/db mice [20] and high fed diet-induced rat models [21] or the non-obese pre-diabetic non-obese diabetic mice model (NOD mice) [22] and the spontaneous T2D model using Goto-Kakaz…”
BackgroundResultmicroRNA profiling in atherosclerosis, diabetes, and migraine
Tana, C., Giamberardino, M. A., & Cipollone, F. (2016) · Annals of Medicine · doi:10.1080/07853890.2016.1226515 · Cited by 62
“Among all, miR-375 expression in knockout mice is necessary to maintain a correct b-cell function as it normalizes glucose tolerance (39,40).”
BackgroundGottmann, P., Ouni, M., Saussenthaler, S., Roos, J., Stirm, L., Jähnert, M., Kamitz, A., Hallahan, N., Jonas, W., Fritsche, A., et al. (2018) · Molecular Metabolism · doi:10.1016/j.molmet.2018.03.005 · Cited by 61
Lei, L., Chao Hui, Z. H. O. U., Yang, X., & Li, L. (2018) · Clinical and Experimental Pharmacology and Physiology · doi:10.1111/1440-1681.12940 · Cited by 59
Mechanisms of statin‐induced new‐onset diabetes
Paseban, M., Butler, A. E., & Sahebkar, A. (2019) · Journal of Cellular Physiology · doi:10.1002/jcp.28123 · Cited by 64
“Several miRNAs that are selectively expressed in pancreatic endocrine cell lines have been identified by Poy et al. (2009). miR‐375 plays an important role in the regulation of glucose‐ stimulated insulin secretion (Tang, Tang, & Özcan, 2008) through an effect on pancreatic β‐cell development.”
BackgroundMicroRNA Networks in Pancreatic Islet Cells: Normal Function and Type 2 Diabetes
Eliasson, L., & Esguerra, J. L. S. (2020) · Diabetes · doi:10.2337/dbi19-0016 · Cited by 59
Expression of microRNAs: potential molecular link between obesity, diabetes and cancer
Ali, A. S., Ali, S., Ahmad, A., Bao, B., Philip, P. A., & Sarkar, F. H. (2011) · Obesity Reviews · doi:10.1111/j.1467-789x.2011.00906.x · Cited by 59
MicroRNA-19b downregulates insulin 1 through targeting transcription factor NeuroD1
Zhang, Z., Zhang, L., Lei, D., Wang, F., Sun, Y.-J., An, Y., Zhao, Y., Li, Y., & Teng, C. (2011) · FEBS Letters · doi:10.1016/j.febslet.2011.06.039 · Cited by 62
MicroRNA signature of the human developing pancreas
Rosero, S., Bravo-Egaña, V., Jiang, Z., Khuri, S., Tsinoremas, N. F., Klein, D., Sabates, E., Correa-Medina, M., Ricordi, C., Domínguez‐Bendala, J., et al. (2010) · BMC Genomics · doi:10.1186/1471-2164-11-509 · Cited by 59
Regulation of microRNA-375 by cAMP in Pancreatic β-Cells
Keller, D. M., Clark, E. A., & Goodman, R. H. (2012) · Molecular Endocrinology · doi:10.1210/me.2011-1205 · Cited by 62
“MiR-375 knockout mice have a 30–40% reduction in -cell mass compared with wild-type controls, whereas they exhibit an increase in -cell mass (22).”
BackgroundAssmann, T. S., Duarte, G. C. K., Brondani, L. D. A., de Freitas, P. H. O., Martins, É. M. B., Canani, L. H. S., & Crispim, D. (2017) · Acta Diabetologica · doi:10.1007/s00592-016-0961-y · Cited by 60
The interplay between noncoding RNAs and insulin in diabetes
Tian, Y., Xu, J. M., Du, X., & Fu, X. (2018) · Cancer Letters · doi:10.1016/j.canlet.2018.01.038 · Cited by 60
Interplay between the miRNome and the epigenetic machinery: Implications in health and disease
Poddar, S., Kesharwani, D., & Datta, M. (2017) · Journal of Cellular Physiology · doi:10.1002/jcp.25819 · Cited by 57
“Poy et al. (2009) have demonstrated that miR-375 plays an important role in normal glucose homeostasis and is highly expressed in pancreatic islets and participates in maintaining α- and β-cells turnover.”
BackgroundA Distinct MicroRNA Signature for Definitive Endoderm Derived From Human Embryonic Stem Cells
Hinton, A. C., Afrikanova, I., Wilson, M., King, C. C., Maurer, B., Yeo, G. W.-M., Hayek, A., & Pasquinelli, A. E. (2009) · Stem Cells and Development · doi:10.1089/scd.2009.0224 · Cited by 65
Yao, Z., Chen, W., Shao, S., Ma, S., Yang, C., Li, M.-Z., Zhao, J., & Gao, L. (2018) · Journal of Zhejiang University SCIENCE B · doi:10.1631/jzus.b1600490 · Cited by 58
“Knockout mice lacking miR-375 (375KO) show the characteristics of hyperglycemia, an increase in total pancreatic α cell numbers, gluconeogenesis, and output of hepatic glucose (Poy et al., 2009).”
BackgroundSalunkhe, V. A., Esguerra, J. L. S., Ofori, J. K., Mollet, I. G., Braun, M., Stoffel, M., Wendt, A., & Eliasson, L. (2015) · Acta Physiologica · doi:10.1111/apha.12460 · Cited by 60
“…of miR-375 in the Na+ channel family To show similar miR-375-mediated regulation between mouse b-cells and rat INS-1 832/13 cells, we measured the expression of miR-375 targets by qPCR previously validated in mouse b-cells such as Mtpn, Cadm1, Cav1, Aifm1 and Gphn (Poy et al. 2009) in OE375 cells.”
BackgroundMethodSelf-citationMicroRNAs in pancreas development
Dumortier, O., & OBBERGHEN, E. V. (2012) · Diabetes Obesity and Metabolism · doi:10.1111/j.1463-1326.2012.01656.x · Cited by 59
Wach, S., Al-Janabi, O., Weigelt, K., Fischer, K., Greither, T., Marcou, M., Theil, G., Nolte, E., Holzhausen, H.-J., Stöhr, R., et al. (2015) · International Journal of Cancer · doi:10.1002/ijc.29505 · Cited by 56
Beta cell secretion of miR-375 to HDL is inversely associated with insulin secretion
Sedgeman, L. R., Beysen, C., Solano, M. A. R., Michell, D. L., Sheng, Q., Zhao, S., Turner, S., Linton, M. F., & Vickers, K. C. (2019) · Scientific Reports · doi:10.1038/s41598-019-40338-7 · Cited by 58
Kuśnierz‐Cabala, B., Nowak, E., Sporek, M., Kowalik, A., Kuźniewski, M., Enguita, F. J., & Stępień, E. Ł. (2015) · Pancreatology · doi:10.1016/j.pan.2015.05.475 · Cited by 55
Relevance of microRNA in metabolic diseases
Price, N. L., Ramírez, C. M., & Fernandez-Hernando, C. F. (2014) · Critical Reviews in Clinical Laboratory Sciences · doi:10.3109/10408363.2014.937522 · Cited by 59
Evaluation of MicroRNA375 as a Novel Biomarker for Graft Damage in Clinical Islet Transplantation
Kanak, M. A., Takita, M., Shahbazov, R., Lawrence, M. C., Chung, W. Y., Dennison, A. R., Levy, M. F., & Naziruddin, B. (2015) · Transplantation · doi:10.1097/tp.0000000000000625 · Cited by 56
“Amore elaborate study usingmiR375 knockout mice demonstrated its importance in the development of β cells.(13) At the same time, gene array analysis of miRNAs in β cells showed no changes in the level of miR375 at different glucose concentrations.”
BackgroundLópez‐Pastor, A. R., Infante‐Menéndez, J., Escribano, Ó., & Gómez‐Hernández, A. (2020) · Frontiers in Medicine · doi:10.3389/fmed.2020.527059 · Cited by 59
Developing microRNA Therapeutics: Approaching the Unique Complexities
Jackson, A. L., & Levin, A. A. (2012) · Nucleic Acid Therapeutics · doi:10.1089/nat.2012.0356 · Cited by 52
Kirkpatrick, C. L., Marchetti, P., Purrello, F., Piro, S., Bugliani, M., Bosco, D., de Koning, E. J. P., Engelse, M. A., Kerr-Conte, J., Pattou, F., et al. (2010) · PLoS ONE · doi:10.1371/journal.pone.0011053 · Cited by 52
“who discovered that insulin and glucagon are co-expressed in a subset of mature mouse beta cells. The mechanism of post-transcriptional regulation is unclear, but could involve islet cell-specific microRNAs. In this context, it is noteworthy that in the miR375 knockout mouse, beta cell mass was decreased and alpha cel…”
BackgroundCUI, F., Wang, S., Lao, I. W., Zhou, C., KONG, H., Bayaxi, N., Li, J., Chen, Q., Zhu, T., & Zhu, H. (2016) · Oncology Reports · doi:10.3892/or.2016.4834 · Cited by 54
Hernández‐Alonso, P., Giardina, S., Salas‐Salvadó, J., Arcelin, P., & Bulló, M. (2016) · European Journal of Nutrition · doi:10.1007/s00394-016-1262-5 · Cited by 56
Epigenetics in formation, function, and failure of the endocrine pancreas
Golson, M. L., & Kaestner, K. H. (2017) · Molecular Metabolism · doi:10.1016/j.molmet.2017.05.015 · Cited by 56
“Mice completely lacking mir-375 display impaired glucose homeostasis, increased a-cell mass, and decreased b-cell mass due to reduced proliferation [103].”
BackgroundmiRNAs as Biomarkers in Diabetes: Moving towards Precision Medicine
Angelescu, M. A., Andronic, O., Dima, S., Popescu, I., Meivar‐Levy, I., Ferber, S., & Lixandru, D. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms232112843 · Cited by 56
Su, Y., Jiang, X., Li, Y., Li, F., Cheng, Y., Peng, Y. H., Song, D., Hong, J., Ning, G., Cao, Y., et al. (2016) · Endocrinology · doi:10.1210/en.2016-1167 · Cited by 57
Injury factors alter miRNAs profiles of exosomes derived from islets and circulation
Fu, Q., Jiang, H., Wang, Z., Wang, X., Chen, H., Shen, Z., Xiao, L., Guo, X., & Yang, T. (2018) · Aging · doi:10.18632/aging.101689 · Cited by 56
“Substantial studies confirmed that miR-3753p is involved in β cell proliferation and secretion function of β and α-cells [32].”
BackgroundFan, K., Spassova, I., Gravemeyer, J., Ritter, C., Horny, K., Lange, A., Gambichler, T., Ødum, N., Schrama, D., Schadendorf, D., et al. (2020) · Oncogene · doi:10.1038/s41388-020-01576-6 · Cited by 56
(Re)generating Human Beta Cells: Status, Pitfalls, and Perspectives
Baeyens, L., Lemper, M., Staels, W., Groef, S. D., Leu, N. D., Heremans, Y., German, M. S., & Heimberg, H. (2018) · Physiological Reviews · doi:10.1152/physrev.00034.2016 · Cited by 62
Rgs16 and Rgs8 in embryonic endocrine pancreas and mouse models of diabetes
Villasenor, A., Wang, Z. V., Rivera, L. B., Ocal, O., Asterholm, I. W., Scherer, P. E., Brekken, R. A., Cleaver, O., & Wilkie, T. M. (2010) · Disease Models & Mechanisms · doi:10.1242/dmm.003210 · Cited by 55
Role of islet microRNAs in diabetes: which model for which question?
Guay, C., & Regazzi, R. (2014) · Diabetologia · doi:10.1007/s00125-014-3471-x · Cited by 52
miR-24 regulates menin in the endocrine pancreas
Vijayaraghavan, J., Maggi, E. C., & Crabtree, J. S. (2014) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00542.2013 · Cited by 52
Role of MicroRNAs in Type 2 Diabetes and Associated Vascular Complications
Banerjee, J., Nema, V., Dhas, Y., & Mishra, N. (2017) · Biochimie · doi:10.1016/j.biochi.2017.05.007 · Cited by 58
Li, L., Jia, L., & Ding, Y. (2018) · Oncology Letters · doi:10.3892/ol.2018.9011 · Cited by 53
Non-Coding RNA in Pancreas and β-Cell Development
Wong, W. K. M., Sørensen, A. E., Joglekar, M. V., Hardikar, A., & Dalgaard, L. T. (2018) · Non-Coding RNA · doi:10.3390/ncrna4040041 · Cited by 66
Role of microRNAs in the age-associated decline of pancreatic beta cell function in rat islets
Tugay, K., Guay, C., Marques, A. C., Allagnat, F., Locke, J. M., Harries, L. W., Rutter, G. A., & Regazzi, R. (2015) · Diabetologia · doi:10.1007/s00125-015-3783-5 · Cited by 50
“Although the role of miRNAs in the regulation of beta cell activities has been investigated in various conditions, including pregnancy and obesity [8–11], the potential contribution of these molecules to age-associated beta cell impairment has not, as yet, been explored.”
BackgroundStem cells as a therapeutic target for diabetes
Mishra, P. K., Singh, S. R., Joshua, I. G., & Tyagi, S. C. (2009) · Frontiers in bioscience · doi:10.2741/3630 · Cited by 58
Novel approaches to drug discovery for the treatment of type 2 diabetes
Xu, X. Y., Wang, G., Zhou, T., Chen, L., Chen, J., & Shen, X. (2014) · Expert Opinion on Drug Discovery · doi:10.1517/17460441.2014.941352 · Cited by 52
“For example, miR-375 was reported to increase b-cell mass in insulin resistance condition [35].”
BackgroundPersonalized Medicine and Type 2 Diabetes: Lesson from Epigenetics
Raciti, G. A., Nigro, C., Longo, M., Parrillo, L., Miele, C., Formisano, P., & Bèguinot, F. (2014) · Epigenomics · doi:10.2217/epi.14.10 · Cited by 53
Biomarkers of β-Cell Stress and Death in Type 1 Diabetes
Mirmira, R. G., Sims, E. K., Syed, F., & Evans‐Molina, C. (2016) · Current Diabetes Reports · doi:10.1007/s11892-016-0783-x · Cited by 52
Biological roles of microRNAs in the control of insulin secretion and action
Caldérari, S., Diawara, M. R., Garaud, A., & Gauguier, D. (2016) · Physiological Genomics · doi:10.1152/physiolgenomics.00079.2016 · Cited by 53
García-Jacobo, R. E., Uresti‐Rivera, E. E., Portales‐Pérez, D. P., González‐Amaro, R., Lara-Ramirez, E. E., Enciso‐Moreno, J. A., & García-Hernández, M. H. (2019) · Clinical and Experimental Pharmacology and Physiology · doi:10.1111/1440-1681.13147 · Cited by 58
The Role of MicroRNAs in Diabetes-Related Oxidative Stress
Qadir, M. M. F., Klein, D., Álvarez-Cubela, S., Domínguez‐Bendala, J., & Pastori, R. L. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20215423 · Cited by 52
Assmann, T. S., Cuevas‐Sierra, A., Riezu‐Boj, J. I., Milagro, F. I., & Martínez, J. A. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21249509 · Cited by 52
Tarang, S., & Weston, M. D. (2014) · RNA Biology · doi:10.4161/rna.28649 · Cited by 55
Insight into miRNAs related with glucometabolic disorder
Zhang, B., Shen, C., Zhu, B.-W., An, H., Zheng, B. J., Xu, S., Sun, J., Sun, P.-C., Zhang, W., Wang, J., et al. (2019) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2018.12.123 · Cited by 49
MicroRNAs in acute pancreatitis: From pathogenesis to novel diagnosis and therapy
Yang, Y., Huang, Q., Luo, C., Wen, Y., Liu, R., Sun, H., & Tang, L. (2019) · Journal of Cellular Physiology · doi:10.1002/jcp.29212 · Cited by 50
“It has been confirmed that miR‐375 that is thought to play an important role in the function of islet B cells abundantly expressed in islet B cells, while pancreatic acinar cells are less abundant (Poy et al., 2009).”
BackgroundAssmann, T. S., Riezu‐Boj, J. I., Milagro, F. I., & Martínez, J. A. (2020) · Journal of Cellular and Molecular Medicine · doi:10.1111/jcmm.14920 · Cited by 50
microRNA-375 regulates glucose metabolism-related signaling for insulin secretion
Dumortier, O., Fabris, G., Pisani, D. F., Casamento, V., Gautier, N., Hinault, C., Lebrun, P., Duranton, C., Tauc, M., Dalle, S., et al. (2019) · Journal of Endocrinology · doi:10.1530/joe-19-0180 · Cited by 49
Argonaute2 Regulates the Pancreatic β-Cell Secretome
Tattikota, S. G., Sury, M. D., Rathjen, T., Wessels, H., Pandey, A. K., You, X. A., Becker, C. F., Chen, W., Selbach, M., & Poy, M. N. (2013) · Molecular & Cellular Proteomics · doi:10.1074/mcp.m112.024786 · Cited by 50
Self-citationPiran, M., Enderami, S. E., Piran, M., Sedeh, H. S., Seyedjafari, E., & Ardeshirylajimi, A. (2016) · Biologicals · doi:10.1016/j.biologicals.2016.12.004 · Cited by 47
Hung, Y.-H., Kanke, M., Kurtz, C. L., Cubitt, R. L., Bunaciu, R. P., Miao, J., Zhou, L., Graham, J. L., Hussain, M. M., Havel, P. J., et al. (2019) · Physiological Genomics · doi:10.1152/physiolgenomics.00037.2019 · Cited by 48
MiR-375: A novel multifunctional regulator
Liu, Y., Wang, Q., Wen, J., Wu, Y., & Man, C. (2021) · Life Sciences · doi:10.1016/j.lfs.2021.119323 · Cited by 50
The regulation of pre- and post-maturational plasticity of mammalian islet cell mass
Mezza, T., & Kulkarni, R. (2014) · Diabetologia · doi:10.1007/s00125-014-3251-7 · Cited by 49
The role of microRNA in nutritional control
Hoen, E. N. M. N., van Rooij, E., Bushell, M., Zhang, C. ‐., Dashwood, R. H., James, W. P. T., Harris, C. C., & Baltimore, D. (2015) · Journal of Internal Medicine · doi:10.1111/joim.12372 · Cited by 48
Regulation of Pancreatic Beta Cell Stimulus-Secretion Coupling by microRNAs
Esguerra, J., Mollet, I., Salunkhe, V., Wendt, A., & Eliasson, L. (2014) · Genes · doi:10.3390/genes5041018 · Cited by 46
MIRNAS: Early Prognostic Biomarkers for Type 2 Diabetes Mellitus?
Bhatia, P., Raina, S., Chugh, J., & Sharma, S. (2015) · Biomarkers in Medicine · doi:10.2217/bmm.15.69 · Cited by 50
Li, N., Jiang, D., He, Q., He, F., Yang, L., Deng, C., & Li, F. (2020) · Cell Death and Disease · doi:10.1038/s41419-020-2668-9 · Cited by 57
Posttranscriptional Regulation of Insulin Resistance: Implications for Metabolic Diseases
Pérez-García, A., Torrecilla-Parra, M., Frutos, M. F.-D., Martín-Martín, Y., Pardo, V., & Ramírez, C. M. (2022) · Biomolecules · doi:10.3390/biom12020208 · Cited by 47
miR-203b: a novel regulator of MyoD expression in tilapia skeletal muscle
Yan, B., Zhao, L.-H., Guo, J.-T., & Zhao, J. (2012) · Journal of Experimental Biology · doi:10.1242/jeb.076315 · Cited by 51
Could microRNAs contribute to the maintenance of β cell identity?
Kaspi, H., Pasvolsky, R., & Hornstein, E. (2014) · Trends in Endocrinology and Metabolism · doi:10.1016/j.tem.2014.01.003 · Cited by 45
The Promise and Challenge of Therapeutic MicroRNA Silencing in Diabetes and Metabolic Diseases
Sethupathy, P. (2016) · Current Diabetes Reports · doi:10.1007/s11892-016-0745-3 · Cited by 47
Molecular mechanisms governing offspring metabolic programming in rodent models of in utero stress
Christoforou, E. R., & Sferruzzi-Perri, A. N. (2020) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-020-03566-z · Cited by 44
Abraham, K. J., Zhang, X., Vidal, R., Paré, G. C., Feilotter, H. E., & Tron, V. A. (2016) · American Journal Of Pathology · doi:10.1016/j.ajpath.2015.11.020 · Cited by 44
New emerging tasks for microRNAs in the control of β-cell activities
Guay, C., & Regazzi, R. (2016) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/j.bbalip.2016.05.003 · Cited by 47
Minireview: MicroRNA Function in Pancreatic β Cells
Özcan, S. (2014) · Molecular Endocrinology · doi:10.1210/me.2014-1306 · Cited by 46
miR-144/451 Promote Cell Proliferation via Targeting PTEN/AKT Pathway in Insulinomas
Jiang, X., Shan, A., Su, Y., Cheng, Y., Gu, W., Wang, W., Ning, G., & Cao, Y. (2015) · Endocrinology · doi:10.1210/en.2014-1966 · Cited by 43
Differentially Expressed MicroRNA-483 Confers Distinct Functions in Pancreatic β- and α-Cells
Mohan, R., Mao, Y., Zhang, S., Zhang, Y.-W., Xu, C., Gradwohl, G., & Tang, X. (2015) · Journal of Biological Chemistry · doi:10.1074/jbc.m115.650705 · Cited by 48
“miR-375, the most abundant miRNA detected in pancreatic islets, plays a key role in maintaining normal -cell and -cell mass in mice (27).”
Seyhan, A. A. (2015) · Molecular BioSystems · doi:10.1039/c5mb00064e · Cited by 45
Serbis, A., Giapros, V. I., Tsamis, K. I., Balomenou, F., Galli‐Τsinopoulou, A., & Siomou, E. C. (2023) · Nutrients · doi:10.3390/nu15092217 · Cited by 46
“In mice, for example, miR-375 is highly expressed in healthy β-cells regulating the expression of several genes that are implicated in normal insulin secretion, such as Glut2, which is involved in glucose uptake, and Pdx-1, which plays a key role in β-cell function [271].”
BackgroundLeptin is required for hypothalamic regulation of miRNAs targeting POMC 3′UTR
Derghal, A., Djelloul, M., Airault, C., Clément, P., Dallaporta, M., Troadec, J., Tillement, V., Tardivel, C., Bariohay, B., Trouslard, J., et al. (2015) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2015.00172 · Cited by 44
“Among these miRNAs, it has been shown that the pancreatic expression levels of mir375 are aberrant in ob/ob mice, indicating that they contribute to insulin resistance in this model (Poy et al., 2009).”
BackgroundMicroRNA Mechanisms of Action: What have We Learned from Mice?
Jin, H. Y., & Xiao, C. (2015) · Frontiers in Genetics · doi:10.3389/fgene.2015.00328 · Cited by 50
“…et al., 2008, 2011, 2012, 2014; Wang et al., 2008, 2013a,b, 2014, 2015a,b; Boettger et al., 2009; Callis et al., 2009; O’Connell et al., 2009, 2010; Poy et al., 2009; Shan et al., 2009; Williams et al., 2009; Xin et al., 2009; Miyaki et al., 2010; Patrick et al., 2010; Yu et al., 2010; Biton et…”
MicroRNA regulation and analytical methods in cancer cell metabolism
Zhang, L.-F., Jiang, S., & Liu, M. (2017) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-017-2508-y · Cited by 44
Takahashi, H., Sakata, N., Yoshimatsu, G., Hasegawa, S., & Kodama, S. (2019) · Journal of Clinical Medicine · doi:10.3390/jcm8020249 · Cited by 43
Xu, Y., Huang, Y., Guo, Y., Xiong, Y., Zhu, S.-J., Xu, L., Lu, J.-J., Li, X.-H., Wan, J., Lu, Y.-H., et al. (2019) · Stem cell research & therapeutics · doi:10.1186/s13287-019-1154-8 · Cited by 32
Metadata
- Authors
- Poy, M. N., Hausser, J., Trajkovski, M., Braun, M., Collins, S., Rorsman, P., Zavolan, M., & Stoffel, M.
- Affiliations
- ETH Zurich (CH)
- SIB Swiss Institute of Bioinformatics (CH)
- Churchill Hospital (GB)
- ORCID
- Venue
- Proceedings of the National Academy of Sciences
- Publisher
- National Academy of Sciences
- Published
- 2009-04-07
- Volume
- 106
- Issue
- 14
- Pages
- 5813-5818
- ISSN
- 0027-8424 (ISSN-L)
- 1091-6490
- PMC
- PMC2656556
- OpenAlex
- W2073803015
- Cited by
- 740
- References
- 36
- Citations by year
- 2026: 16 · 2025: 17 · 2024: 23 · 2023: 26 · 2022: 35 · 2021: 38 · 2020: 39 · 2019: 52 · 2018: 47 · 2017: 58 · 2016: 59 · 2015: 67 · 2014: 72 · 2013: 60 · 2012: 53
- FWCI
- 43.94
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Proceedings of the National Academy of Sciences (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Archive ouverte UNIGE (University of Geneva) (submittedVersion, cc-by)
- Funders
- Wellcome Trust
- Schweizerischer Nationalfonds zur Förderung der Wissenschaftlichen Forschung (114001, 3100A0)
- National Institutes of Health
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Pancreatic function and diabetes
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › MicroRNA in disease regulation
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Diabetes and associated disorders
- Keywords
- miR-375, microRNA, alpha cells, pancreatic beta cells, beta-cell mass, glucose homeostasis, hyperglycemia, glucagon, gluconeogenesis, hepatic glucose production, beta-cell proliferation, islet development, obesity, insulin resistance, diabetes mellitus, cell proliferation
- MeSH terms
- Animals, Blood Glucose, Homeostasis, Insulin, Islets of Langerhans, Mice, Obese, Mice, Knockout, MicroRNAs, Cell Proliferation, Glucagon-Secreting Cells, Insulin-Secreting Cells, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.